Optimizing utilization of sacubitril/valsartan for treatment of heart failure could improve provider performance in the Bundled Payments for Care Improvement initiative and the Medicare Shared Savings Program.
Cheryl Abbas, PharmD
Advertisement
Articles by Cheryl Abbas, PharmD
Advertisement
Latest Updated Articles
Sacubitril/Valsartan in Medicare Alternative Payment ModelsMarch 14th 2023
Advertisement
Advertisement
Trending on AJMC
1
US Employer Health Care Costs Projected to Rise 9.5% in 2027
2
FDA Approves Nipocalimab-aahu as First Treatment for wAIHA
3
FDA Clears First Single-Biomarker Blood Test for Alzheimer
4
Lung Cancer Task Force Maps Research Roadmap to Close Survival Gap
5